-+ 0.00%
-+ 0.00%
-+ 0.00%

IN8bio Q2 EPS $(0.25) Beats $(0.37) Estimate

Benzinga·08/06/2026 21:58:36
Listen to the news
IN8bio (NASDAQ:INAB) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.37) by 32.43 percent. This is a 79.84 percent increase over losses of $(1.24) per share from the same period last year.